Breaking News

Kemwell Completes Joint cGMP Audit

July 8, 2014

Gains certification by Belgium and EU authorities

Kemwell Biopharma has successfully completed a cGMP joint audit by The Federal Agency for Medicines and Health Products, Belgium and the Medical Products Agency (MPA), of its oral solids manufacturing facility in Bangalore, India, receiving a certificate of GMP compliance as a manufacturer, which is valid for three years.
The audit was performed as part of the European Medicines Agency's (EMA) evaluation of the Marketing Authorization Application for a NCE for a top global pharma company and as a scheduled renewal audit.
According to Anurag Bagaria, chairman and managing director, “Kemwell understands the need to maintain high quality standards and to deliver products to our customers on-time. Through an unwavering commitment to continuous improvement, we supply products to over 80 countries worldwide with an assured level of quality and value. This positive audit underscores the high standards Kemwell upholds in contract manufacturing of products for commercial use and for products under development in compliance with rigorous international standards.”
  • Packaging Equipment Technology Preview

    Packaging Equipment Technology Preview

    February 15, 2017
    Today’s complex drug products present challenges; the latest equipment capabilities help overcome them

  • The Good, the Bad, and the Donald

    The Good, the Bad, and the Donald

    January 31, 2017
    Orphan drugs, CMO continuous manufacturing and developing world sales offer biggest revenue opportunities

  • Predictive Analytics and the Future of RBM

    Rajneesh Patil, Senior Director, RBM and Analytics, QuintilesIMS||January 23, 2017
    How advances in Risk-Based Monitoring will enable a more proactive approach to identify and mitigate potential risks